MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression

Oncogene. 2000 Sep 21;19(40):4647-59. doi: 10.1038/sj.onc.1203820.

Abstract

The MGSA/GRO protein is endogenously expressed in almost 70% of the melanoma cell lines and tumors, but not in normal melanocytes. We have previously demonstrated that over-expression of human MGSA/GROalpha, beta or gamma in immortalized murine melanocytes (melan-a cells) enables these cells to form tumors in SCID and nude mice. To examine the possibility that the MGSA/GRO effect on melanocyte transformation requires expression of other genes, differential display was performed. One of the mRNA's identified in the screen as overexpressed in MGSA/GRO transformed melan-a clones was the newly described M-Ras or R-Ras3 gene, a member of the Ras gene superfamily. Over-expression of MGSA/GRO upregulates M-Ras expression at both the mRNA and protein levels, and this induction requires an intact glutamine-leucine-arginine (ELR)-motif in the MGSA/GRO protein. Western blot examination of Ras expression revealed that K- and N-Ras proteins are also elevated in MGSA/GRO-expressing melan-a clones, leading to an overall increase in the amount of activated Ras. MGSA/GRO-expressing melan-a clones exhibited enhanced AP-1 activity. The effects of MGSA/GRO on AP-1 activation could be mimicked by over-expression of wild-type M-Ras or a constitutively activated M-Ras mutant in control melan-a cells as monitored by an AP-1-luciferase reporter, while expression of a dominant negative M-Ras blocked AP-1-luciferase activity in MGSA/GRO-transformed melan-a clones. In the in vitro transformation assay, over-expression of M-Ras mimicked the effects of MGSA/GRO by inducing cellular transformation in control melan-a cells, while over-expression of dominant negative M-Ras in MGSA/GROalpha-expressing melan-a-6 cells blocked transformation. These data suggest that MGSA/GRO-mediated transformation requires Ras activation in melanocytes.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Autocrine Communication / physiology
  • Cell Line, Transformed / metabolism
  • Cell Transformation, Neoplastic / genetics*
  • Chemokine CXCL1
  • Chemokines, CXC*
  • Chemotactic Factors / biosynthesis
  • Chemotactic Factors / genetics
  • Chemotactic Factors / physiology*
  • Clone Cells
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic*
  • Genes, Reporter
  • Genes, ras*
  • Growth Substances / biosynthesis
  • Growth Substances / genetics
  • Growth Substances / physiology*
  • Humans
  • Intercellular Signaling Peptides and Proteins*
  • MAP Kinase Signaling System
  • Melanocytes / pathology*
  • Melanoma / genetics
  • Melanoma / pathology
  • Mice
  • Monomeric GTP-Binding Proteins / biosynthesis
  • Neoplasm Proteins / biosynthesis
  • Neoplasm Proteins / genetics
  • Protein Isoforms / biosynthesis
  • Protein Isoforms / genetics
  • RNA, Messenger / biosynthesis
  • RNA, Neoplasm / biosynthesis
  • Receptors, Cytokine / physiology
  • Recombinant Fusion Proteins / physiology
  • Signal Transduction
  • Subtraction Technique
  • Transcription Factor AP-1 / physiology
  • Transfection
  • ras Proteins

Substances

  • CXCL1 protein, human
  • Chemokine CXCL1
  • Chemokines, CXC
  • Chemotactic Factors
  • Cxcl1 protein, mouse
  • Growth Substances
  • Intercellular Signaling Peptides and Proteins
  • Neoplasm Proteins
  • Protein Isoforms
  • RNA, Messenger
  • RNA, Neoplasm
  • Receptors, Cytokine
  • Recombinant Fusion Proteins
  • Transcription Factor AP-1
  • melanoma growth stimulating activity receptor
  • Mras protein, mouse
  • Monomeric GTP-Binding Proteins
  • ras Proteins